Duchenne Muscular Dystrophy (DMD): Symptoms, Causes, Life Expectancy and Treatment
Written by the Muscular Dystrophy Pakistan (MDP) content team. Based on information from NINDS, MedlinePlus Genetics, Parent Project Muscular Dystrophy and published reviews (see sources below). Last updated: October 8, 2026.
Duchenne muscular dystrophy, usually called DMD, is the most common form of muscular dystrophy in children. Hearing this diagnosis for your child is one of the hardest moments a parent can face, and the internet is full of frightening numbers and confusing treatment names. This guide explains Duchenne in simple words: what it is, what causes it, the symptoms and stages, what we know about life expectancy today, the treatments that exist, and what families in Pakistan can do. It is written to inform, not to frighten, because families with knowledge make better decisions and find more support.
Quick facts
- Duchenne affects roughly 1 in every 3,600 to 6,000 live male births worldwide, and mostly boys.
- It is caused by changes in the DMD gene on the X chromosome, which leads to a missing or non-working muscle protein called dystrophin.
- Symptoms usually become noticeable between ages 2 and 5. Muscle weakness slowly gets worse over the years.
- There is no complete cure yet, but steroids, heart and breathing care, and newer therapies have helped many people live longer and better lives.
- Early diagnosis and regular care by a team of specialists make a real difference.
What Is Duchenne Muscular Dystrophy?
Duchenne is a genetic condition in which muscles gradually become weaker and are slowly replaced by fat and scar tissue. It first affects the muscles of the hips, thighs and shoulders, and later the arms, the heart and the breathing muscles. It is named after the French neurologist Guillaume Duchenne, who described it in the 1800s.
Duchenne is not contagious, and it is not caused by anything the parents did or did not do. It is not caused by diet, vaccines, injuries or the evil eye. It is a condition written in a gene.
What Causes Duchenne?
Duchenne is caused by changes (mutations) in the DMD gene, the recipe for a protein called dystrophin. Dystrophin acts like a shock absorber inside muscle fibres and protects them while they contract. In Duchenne, almost no working dystrophin is made, so the muscle fibres are damaged again and again and cannot repair themselves properly. The most common type of change is a large deletion, where one or more sections of the gene are missing.
The DMD gene is on the X chromosome, which is why Duchenne is inherited in an X-linked recessive pattern:
- Boys have one X chromosome, so one changed copy is enough to cause Duchenne.
- Girls have two X chromosomes. Most girls who carry one changed copy are healthy carriers, because the second copy works as a backup. Some carriers may have mild muscle weakness or heart involvement.
- A carrier mother has a 50% chance with each son of passing the change on, and a 50% chance with each daughter of her being a carrier.
- In some boys, the gene change is new, and there is no earlier family history. Even then, a small chance remains for another affected child, so genetic counselling is advised.
- Duchenne is not caused by cousin marriage. It can happen in any family.
A boy with a milder change that leaves some working dystrophin has Becker muscular dystrophy, a related but milder condition.
Symptoms of Duchenne Muscular Dystrophy
Most boys with Duchenne look healthy as babies. The first signs are usually noticed at around 2 to 5 years of age:
- Late walking, or walking that is clumsy from the beginning
- Frequent falls and trouble running, jumping or climbing stairs
- A waddling walk and walking on the toes
- Large-looking calf muscles that are actually weak
- Gowers' sign: using the hands to "climb up" the legs to stand up from the floor
- Tiredness, leg pain and difficulty keeping up with other children
- Delayed speech, learning difficulties or attention problems in some boys
If you notice these signs in a child, please read our guide on the early signs of muscular dystrophy in children and ask a doctor about a CPK blood test.
How Duchenne Progresses: The Stages
Duchenne gets worse slowly over many years. The pattern is similar in most boys, but the speed differs from child to child, and treatment can change the course.
| Stage | Typical age | What families may notice |
|---|---|---|
| Early signs | Toddler to about 5 years | Late walking, falls, waddling, trouble with stairs, large calves |
| Walking, but weaker | About 5 to early teens | Getting tired more easily, harder to climb stairs or rise from the floor, tight heels and ankles |
| Loss of independent walking | Often in the early to mid teens | Needs support or a wheelchair for longer distances and later for all movement. Steroids can delay this |
| Teenage and adult years | Late teens onward | Arm weakness, spine curvature in some, and growing importance of heart and breathing checks |
The age at which a boy stops walking has been reported at around 12 years on average in studies, and corticosteroid treatment can delay it. Because every child is different, your specialist is the best person to talk about what to expect.
Duchenne and the Heart and Lungs
Muscle is not only in the arms and legs. The heart is a muscle, and so are the muscles used for breathing and coughing. In Duchenne, the heart muscle can become weak (cardiomyopathy) and the breathing muscles weaken gradually, usually in the teenage years and later. This is why regular heart checks (ECG and echocardiogram or cardiac MRI) and breathing tests should be part of care, even when the boy feels well. Treating problems early protects health and quality of life.
Life Expectancy in Duchenne: What We Know Today
This is the question every parent is afraid to ask, so let us answer it honestly and gently.
- In the past, before modern care, most people with Duchenne lived only into their late teens or early twenties.
- With today's care in countries with strong health systems, which includes steroids, regular heart treatment, and breathing support when needed, many people with Duchenne now live into their 20s and 30s, and some into their 40s. Studies report median survival between about 21 and 40 years for patients who receive ventilator support, and lower figures for those who do not.
- These numbers come from studies in countries with specialised care. We do not have reliable survival data for Pakistan, and access to specialist care here is limited and uneven, so outcomes can differ.
- These are averages, not predictions. No number can tell you what will happen to your child. Care, early diagnosis and new treatments keep changing the picture.
The most important message is this: good care changes outcomes. Heart treatment, breathing support, bone health, infection prevention and emotional support all add years and quality to life.
Diagnosis
Diagnosis starts with a doctor's examination and a CPK blood test, which is usually very high in Duchenne. A genetic test then confirms the diagnosis and finds the exact gene change, which matters for treatment options, for testing carrier relatives, and for family planning. A muscle biopsy is needed only when genetic testing is not available or does not give a clear answer. In Pakistan there is no routine newborn screening for muscular dystrophy, so the signs noticed at home are often the first alarm. Read more in our guide on how muscular dystrophy is diagnosed.
Treatment and Care for Duchenne
There is no complete cure for Duchenne yet, but there are treatments that can slow the loss of muscle strength and protect the heart and lungs. Care works best when a team of specialists works together with the family.
1. Corticosteroids: the standard of care
Steroid medicines, such as prednisolone and deflazacort, are the long-standing standard treatment. Used under specialist supervision, they can slow the decline in muscle strength and may delay the loss of walking by a couple of years. They can also have side effects, such as weight gain, slower growth, thinner bones, mood changes and cataracts, so the doctor monitors the child carefully. Steroids must never be started, changed or stopped suddenly without the doctor's advice.
2. Newer medicines
- Vamorolone is a newer steroid-like medicine, approved in the United States, the European Union and the United Kingdom as an alternative to standard steroids, designed to be gentler on growth and bones.
- Givinostat is a daily oral medicine that targets inflammation and muscle damage. It was approved in the United States in 2024 for boys aged 6 and older, whatever their gene change.
- Exon-skipping medicines (such as eteplirsen, golodirsen, viltolarsen and casimersen) work only for certain gene changes, for example those that can be corrected by skipping exon 51, 53 or 45. Each helps a limited group of patients and is given by regular infusions.
- Gene therapy (a one-time infusion delivering a shortened version of the dystrophin gene) has been approved in the United States for some walking children aged 4 and older. Its benefits and risks are still being studied, serious liver problems have been reported, and regulators have placed limits on its use, so it must be discussed carefully with a specialist.
What this means in Pakistan: To our knowledge, most of these newer medicines are not available in Pakistan, and they are extremely expensive even where they are. Steroids are widely available as generic medicines. Your specialist can tell you what is realistic for your child, and whether the exact gene change qualifies for any therapy or clinical trial in the future. This is another reason why a genetic report matters.
3. Heart care
Regular heart checks and, when needed, heart medicines (such as ACE inhibitors) help to protect the heart. Many specialists recommend starting heart checks at diagnosis and continuing them regularly.
4. Breathing care
Breathing tests, a plan for chest infections, cough assistance, and night-time breathing support when needed help to keep the lungs healthy. Flu and pneumococcal vaccines are usually advised.
5. Bone health, nutrition and weight
Steroids and reduced movement can weaken bones, so doctors check vitamin D, calcium and fracture risk. A balanced diet and healthy weight matter, because being overweight makes walking harder, and being underweight is also a problem in later stages. Swallowing problems should be reported to the doctor.
6. Safety with surgery and anaesthesia
Always tell every doctor, dentist and anaesthetist that your child has Duchenne muscular dystrophy before any operation or procedure. Some anaesthetic medicines can be dangerous for people with muscular dystrophy, and the anaesthetic team must plan carefully.
7. Emotional and family support
Boys with Duchenne usually have a normal mind and big dreams. They and their parents and siblings need emotional support, school support and a community that does not blame or isolate them.
Duchenne in Girls and Women
Duchenne mostly affects boys, but girls and women who are carriers can be mildly affected. Some have muscle weakness, cramps or tiredness, and some can have heart involvement. Carriers should have a heart check, and sisters and female cousins of an affected boy should consider genetic counselling and testing.
Duchenne and Families in Pakistan
For families in Pakistan, the biggest challenges are late diagnosis, few specialists, the cost of genetic testing and treatment, long distances to big cities, and stigma, with mothers often being blamed. There is also no national registry that counts patients. That is why Muscular Dystrophy Pakistan is collecting patient data on its registration portal: the more families are counted, the stronger the case for better diagnosis, care and support. If your family is affected, please register below.
Frequently Asked Questions
Is Duchenne muscular dystrophy curable?
Not yet. Current treatments slow its course and protect the heart and lungs, and research on new treatments, including gene therapies, is active.
At what age is Duchenne usually diagnosed?
Signs usually appear between ages 2 and 5, but the diagnosis is often made later because the early signs are missed. An earlier CPK test and genetic test can shorten the wait.
Will my son be able to walk?
Most boys with Duchenne walk for the first years of life, and many lose independent walking in their early to mid teens. Steroids can delay this. Every boy is different.
Can a boy with Duchenne go to school?
Yes. Most boys with Duchenne have normal intelligence, and some have learning or attention difficulties that can be supported. Accessible classrooms, understanding teachers and protection from bullying make a big difference.
Can I have more children?
Many families do. A genetic counsellor can explain the chance of another affected child, depending on whether the mother is a carrier, and the options available. These are personal decisions made by the family.
Does exercise help or hurt?
Gentle, everyday activity is generally encouraged, while very heavy or exhausting exercise can damage weak muscles. Ask the specialist what is suitable for your child.
Are there special diets or supplements that cure Duchenne?
No. Please be careful of products sold as "cures". A balanced diet, vitamin D and calcium as advised by the doctor, and a healthy weight are what is helpful.
Hope Through Knowledge and Care
A Duchenne diagnosis changes a family's life, but it does not take away a child's worth, mind or dreams. Early diagnosis, the right specialists, regular heart and breathing care, honest information and a supportive community can make the road easier. Follow the MDP blog for our upcoming guides on each type of muscular dystrophy, and share this article with a parent who may need it.
Sources and Further Reading
- National Institute of Neurological Disorders and Stroke (NINDS), Muscular Dystrophy information page
- MedlinePlus Genetics, Duchenne and Becker muscular dystrophy
- Parent Project Muscular Dystrophy, Genetic Causes of Duchenne and Becker
- Parent Project Muscular Dystrophy, Approved Therapies for Duchenne Muscular Dystrophy
- Ryder S et al., The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review, Orphanet Journal of Rare Diseases
- Clinico-genetic heterogeneity in Pakistani families affected with muscular dystrophies, PubMed Central
Medical disclaimer: This article is for awareness and education only. It is not a substitute for professional medical advice, diagnosis or treatment. Please consult a qualified doctor about any medical concern. Never start, change or stop a medicine without your doctor's advice.
Comments
Post a Comment